Condition: Prurigo Nodularis (PN) · Sponsor: Beijing InnoCare Pharma Tech Co., Ltd.
Evaluate the efficacy and safety of ICP-332 in participants with Prurigo Nodularis (PN)
This description comes directly from the study's public registry record.
Alexia Lu · +86-010-66609745 · CO_HGRAC@innocarepharma.com
Always discuss trial participation with your own doctor first.
| Cahaba Dermatology and Skin Health Center | Birmingham, Alabama, United States | Recruiting |
| Medical Dermatology Specialists | Phoenix, Arizona, United States | Recruiting |
| Driven Research, LLC | Coral Gables, Florida, United States | Recruiting |
| Cordova Research Institute | Sweetwater, Florida, United States | Recruiting |
| Dawes Fretzin Clinical Research Group LLC | Indianapolis, Indiana, United States | Recruiting |
| The Derm Institute of West Michigan | Caledonia, Michigan, United States | Recruiting |
| Revival Research Institute, LLC | Troy, Michigan, United States | Recruiting |
| Minnesota Clinical Study Center | New Brighton, Minnesota, United States | Recruiting |
| Skin Specialists, PC | Omaha, Nebraska, United States | Recruiting |
| Apex Clinical Research Center | Mayfield Heights, Ohio, United States | Recruiting |
| The Second Affiliated Hospital of Wannan Medical College | Wuhu, Anhui, China | Recruiting |
| Peking University People's Hospital | Beijing, Beijing Municipality, China | Recruiting |
+ 22 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07236099